Patent Oppositions in form specific drugs industry

Explore the competitive field of form specific drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in form specific drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the form specific drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the form specific drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Nov 5, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSNov 4, 2026WITHERS & ROGERS GREG STEPNEY HOWARD WRIGHT NICHOLAS WALLIN
Improved Aquaculture Feed AdditiveHP INGREDIENTSNov 3, 2026MAQUI NEW LIFE
Stable, Concentrated Radionuclide Complex SolutionsADVANCED ACCELERATOR APPLICATIONSNov 3, 2026LUMARA BIO ONCOLOGICS
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARMOct 28, 2026LEPTHIEN
Manufacture Of DegarelixFERRINGOct 28, 2026ACCORD HEALTHCARE SLU
Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal IrinotecanIPSEN BIOPHARMOct 27, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Composition For Solid Preparation Comprising Hydroxypropyl Methyl Cellulose, Solid Preparation, And Method For Producing The SameSHIN ETSU CHEMICALOct 26, 2026NUTRITION & BIOSCIENCES USA 1
Ophthalmic Liquid CompositionPANGEN BIOTECHOct 21, 2026EIP
Orodispersible Powder CompositionBIOPHARMA SYNERGIESSep 29, 2026PHARMA PATENTS
Dosage Forms For Tyk2 InhibitorsBRISTOL MYERS SQUIBBSep 24, 2026KERNEBECK PATENTANWALTS

To stay ahead in the competitive form specific drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the form specific drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Nov 5, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Nov 26, 2025High Concentration Vegf Receptor Fusion Protein Containing FormulationsREGENERON PHARMACEUTICALS13
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND12
Jan 21, 2015Bisphosphonic Acids For The Treatment And Prevention Of OsteoporosisATNAHS PHARMA UK12
Aug 20, 2025Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-DioneAMGEN EUROPE12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Jun 3, 2015Pharmaceutical Preparation Containing Oxycodone And NaloxoneEURO CELTIQUE11
Dec 16, 2015Apixaban FormulationsBRISTOL MYERS SQUIBB11
Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11